Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
180 participants
INTERVENTIONAL
2009-07-31
2019-03-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Triathlon TS Knee
Triathlon TS Knee System
Triathlon TS Knee System
Total knee replacement for revision cases
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Triathlon TS Knee System
Total knee replacement for revision cases
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient is a male or non-pregnant female age 18 years or older at time of study device implantation.
* Patient is a candidate for revision of all femoral and tibial components of a total knee replacement.
* Patient is willing and able to comply with postoperative scheduled clinical and radiographic evaluations and rehabilitation.
Exclusion Criteria
* Patient has an active or suspected latent infection in or about the affected knee joint at time of study device implantation.
* Patient has a neuromuscular or neurosensory deficiency, which limits the ability to evaluate the safety and efficacy of the device.
* Patient is diagnosed with a systemic disease (e.g. Lupus Erythematosus) or a metabolic disorder (e.g. Paget's Disease) leading to progressive bone deterioration.
* Patient is immunologically suppressed or receiving steroids in excess of normal physiological requirements (e.g. \> 30 days).
* Patient has a failed unicondylar knee prosthesis.
* Patient has a known sensitivity to device materials.
* Patient is a prisoner.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stryker Orthopaedics
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kirby D Hitt, M.D.
Role: STUDY_CHAIR
Scott & White Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The CORE Institute
Phoenix, Arizona, United States
Heekin Institute for Orthopedic Research
Jacksonville, Florida, United States
Midwest Orthopaedics at Rush
Chicago, Illinois, United States
Tufts Medical Center
Boston, Massachusetts, United States
Rothman Institute
Egg Harbor, New Jersey, United States
Ridgewood Orthopedics
Ridgewood, New Jersey, United States
Upstate Bone and Joint Center
East Syracuse, New York, United States
University of North Carolina Orthopedics
Chapel Hill, North Carolina, United States
Duke University Medical Center
Durham, North Carolina, United States
Wellington Orthopaedic & Sports Medicine
Cincinnati, Ohio, United States
The Orthopaedic Center
Tulsa, Oklahoma, United States
Scott & White Clinic
Temple, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
65
Identifier Type: -
Identifier Source: org_study_id